Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
LY2603618 is a checkpoint kinase 1 (Chk1) inhibitor (IC50 = 7 nM) that prevents the repair of DNA caused by DNA-damaging agents.1 It can inhibit Chk1 autophosphorylation and increase DNA damage-mediated Chk1 phosphorylation.2 LY2603618 has been used in xenograft tumor models to potentiate the antitumor efficacy of chemotherapeutic agents such as gemcitabine (Item No. 11690).3
WARNING This product is not for human or veterinary use.
1. Characterization and preclinical development of LY2603618: A selective and potent Chk1 inhibitor. Invest New Drugs 32(2), 213-226 (2014).
2. The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells. Apoptosis 19(9), 1389-1398 (2014).
3. LY2603618, a selective CHK1 inhibitor, enhances the anti-